234 related articles for article (PubMed ID: 7899316)
1. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
2. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection.
Reddy MM; Grieco MH
Int J STD AIDS; 1991; 2(2):128-32. PubMed ID: 2043705
[TBL] [Abstract][Full Text] [Related]
4. [Cellular immunity in pregnancy-induced hypertensive diseases].
Schröcksnadel H; Herold M; Steckel-Berger G; Fuchs D; Wachter H; Dapunt O
Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):592-5. PubMed ID: 1294433
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.
Tilg H; Vogel W; Tratkiewicz J; Aulitzky WE; Herold M; Gruber M; Geissler D; Umlauft F; Judmaier G; Schwulera U
J Hepatol; 1993 Sep; 19(2):259-67. PubMed ID: 8301059
[TBL] [Abstract][Full Text] [Related]
6. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
[TBL] [Abstract][Full Text] [Related]
7. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.
Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H
Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599
[TBL] [Abstract][Full Text] [Related]
8. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis.
Hosp M; Elliott AM; Raynes JG; Mwinga AG; Luo N; Zangerle R; Pobee JO; Wachter H; Dierich MP; McAdam KP; Fuchs D
Lung; 1997; 175(4):265-75. PubMed ID: 9195554
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users.
Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB
AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum and urine neopterin concentrations in patients with HIV-1 infection.
Fuchs D; Jaeger H; Popescu M; Reibnegger G; Werner ER; Kaboth W; Wachter H
Clin Chim Acta; 1990 Feb; 187(2):125-30. PubMed ID: 2317931
[TBL] [Abstract][Full Text] [Related]
11. Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Microbiol; 1989 Sep; 27(9):1919-23. PubMed ID: 2789233
[TBL] [Abstract][Full Text] [Related]
12. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
13. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.
Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465
[TBL] [Abstract][Full Text] [Related]
14. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
Neurology; 1991 Jan; 41(1):69-74. PubMed ID: 1898675
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.
Re MC; Zauli G; Furlini G; Giovannini M; Ranieri S; Ramazzotti E; Vignoli M; La Placa M
Microbiologica; 1992 Jul; 15(3):265-70. PubMed ID: 1354325
[TBL] [Abstract][Full Text] [Related]
16. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
Noronha IL; Daniel V; Schimpf K; Opelz G
Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
[TBL] [Abstract][Full Text] [Related]
17. Cytokine network and acute primary HIV-1 infection.
Sinicco A; Biglino A; Sciandra M; Forno B; Pollono AM; Raiteri R; Gioannini P
AIDS; 1993 Sep; 7(9):1167-72. PubMed ID: 8216972
[TBL] [Abstract][Full Text] [Related]
18. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
19. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
